Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

Prevalence of oral corticosteroid use in the German severe asthma population

Christian Taube, Peter Bramlage, Annette Hofer, Dörte Anderson
ERJ Open Research 2019 5: 00092-2019; DOI: 10.1183/23120541.00092-2019
Christian Taube
1Dept of Pulmonary Medicine, University Hospital Essen – Ruhrlandklinik, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: christian.taube@rlk.uk-essen.de
Peter Bramlage
2Institut für Pharmakologie und Präventive Medizin, Cloppenburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter Bramlage
Annette Hofer
3AstraZeneca GmbH, Wedel, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dörte Anderson
3AstraZeneca GmbH, Wedel, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dörte Anderson
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 5 no. 4
DOI 
https://doi.org/10.1183/23120541.00092-2019

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received April 11, 2019
  • Accepted August 8, 2019
  • Published online October 30, 2019.

Copyright & Usage 
Copyright ©ERS 2019 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Christian Taube1⇑,
  2. Peter Bramlage2,
  3. Annette Hofer3 and
  4. Dörte Anderson3
  1. 1Dept of Pulmonary Medicine, University Hospital Essen – Ruhrlandklinik, Essen, Germany
  2. 2Institut für Pharmakologie und Präventive Medizin, Cloppenburg, Germany
  3. 3AstraZeneca GmbH, Wedel, Germany
  1. Christian Taube, Dept of Pulmonary Medicine, University Hospital Essen – Ruhrlandklinik, Tüschener Weg 40, 45239 Essen, Germany. E-mail: christian.taube{at}rlk.uk-essen.de
View Full Text

Funding

  • AstraZeneca

    n.a.

Article usage

Article usage: October 2019 to October 2023

AbstractFullPdf
Oct 201905915
Nov 2019731366
Dec 20191014354
Jan 2020716946
Feb 20201212930
Mar 20201111126
Apr 202014416
May 202027323
Jun 202025910
Jul 20203349
Aug 202018733
Sep 202075726
Oct 202054717
Nov 20202448
Dec 202093413
Jan 202193810
Feb 202123212
Mar 202175010
Apr 20213407
May 202153615
Jun 202135520
Jul 202113223
Aug 202138220
Sep 202155021
Oct 2021711123
Nov 202104130
Dec 20210286
Jan 20223295
Feb 202224312
Mar 20228537
Apr 202262011
May 202234028
Jun 202244011
Jul 202224818
Aug 202215478
Sep 202244521
Oct 202263520
Nov 20228795
Dec 202213827
Jan 202335013
Feb 202314116
Mar 202353213
Apr 202342714
May 202363010
Jun 202364616
Jul 202362534
Aug 202303012
Sep 20233334
Oct 202342212

Altmetrics

PreviousNext
Back to top
Vol 5 Issue 4 Table of Contents
ERJ Open Research: 5 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prevalence of oral corticosteroid use in the German severe asthma population
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Prevalence of oral corticosteroid use in the German severe asthma population
Christian Taube, Peter Bramlage, Annette Hofer, Dörte Anderson
ERJ Open Research Oct 2019, 5 (4) 00092-2019; DOI: 10.1183/23120541.00092-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prevalence of oral corticosteroid use in the German severe asthma population
Christian Taube, Peter Bramlage, Annette Hofer, Dörte Anderson
ERJ Open Research Oct 2019, 5 (4) 00092-2019; DOI: 10.1183/23120541.00092-2019
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Asthma and allergy
  • Epidemiology, occupational and environmental lung disease
  • Pulmonary pharmacology and therapeutics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original articles

  • Endobronchial autologous BM-MSCs in IPF patients
  • Effect of β-blockers on the risk of COPD exacerbations
  • Recurrence of symptoms after childhood LRTI
Show more Original articles

Asthma

  • Benralizumab in severe eosinophilic asthma in real life
  • COVID-19 vaccination in asthma
  • VTE associated with severe dyspnoea and asthma in adults
Show more Asthma

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society